On 10 June 2013, a total of 10 benzofuran and indole analogues and four NBOMe hallucinogens were classified as Temporary Class Drugs in the UK following an ACMD recommendation.
On 31 March 2015, five derivatives of methylphenidate were recommended to be banned in the UK as Temporary Class Drugs following their sale as uncontrolled stimulant drugs.